shutterstock_351691121.jpg

United and Achieve Life

Carrimycin Create More Hope For Lives

OUR COVID-19 STUDY - WHAT'S NEXT?
READ THE UPDATE

 

New Drug Carrimycin

Carrimycin is tongliangroup latest technology and product contribution to global public health and life health. Based on the long-term research results of genetic engineering drugs, our scientists have successfully developed Chinese Class 1.1 innovative drugs with clinical application value using "synthetic biology technology" for the first time in the world.

Rifampicin

We are committed to relieving the disease and suffering of TB patients who account for one-third of the world's total population. We have worked closely with scientists, medical scientists, and doctors to develop and produce Rifampicin, the first-line drug of choice for treating tuberculosis. 

adsadadd.jpg

  • Jan 05, 2021

    FDA approves Phase III trial of synthetic biological COVID-19 treatment

    Carrimycin includes antiviral, anti-inflammatory and anti-fibrosis effects in addition to its antibacterial effect.Carrimycin has become the world's first synthetic biological drug treatment for severe COVID-19 to receive U.S. Food and Drug Administration approval for Phase III trials.

    Read More
  • shutterstock_1712032447.jpg

    Apr 15, 2020

    New Progress Made in China’s Treatment of COVID-19

    At the press conference of the Joint Prevention and Control Mechanism of the State Council held at 15:00 on April 14th, relevant officials from the Ministry of Science and Technology of the PRC, the National Administration of Traditional Chinese Medicine...

    Read More
  • shutterstock_1686998698.jpg

    Mar 27, 2020

    Ministry of Science and Technology of the PRC: Carrimycin IS Effective In The Treatment of COVID-19

    On March 26, the State Council Information Office of the PRC held a press conference where relevant officials from the Ministry of Foreign Affairs, the Ministry of Science and Technology...

    Read More
  • shutterstock_1642228681.jpg

    Mar 26, 2020

    Chinese Primary Drug Carrimycin is Effective in the Treatment of COVID-19

    At 10:00 on March 26, 2020, the State Council Information Office of the PRC held a press conference where Luo Zhaohui, Vice Foreign Minister, Xu Nanping, Deputy Minister of Science and Technology, Zeng Yixin...

    Read More
  • shutterstock_1697330878.jpg

    Jan 16, 2020

    Carrimycin, Chinese Academy of Medical Sciences Won National Awards and Received Global Attention

    At noon on January 11, 2020, the China Top 10 Advancement Projects in Pharmaceutical Biotechnology in 2019 were officially announced. Carrimycin, jointly developed...

    Read More
  • shutterstock_1679374246.jpg

    Jan 04, 2020

    Carrimycin Firstly Appeared in the Official List of Effective Drugs Against COVID-19

    April 1, China News ，for the first time, Carrimycin produced in Songjiang District appeared on the official list of effective drugs against COVID-19...

    Read More
shutterstock_1154866195_edited.jpg
People-oriented, Serving the society.
 

Continuously improve the value of human life

Scientific and Technological Association, Cultural Association, and Quality Association

Create an innovative world-class new association with high-tech content, high cultural added value, and high market share.

 

Contact

Opening Hours

Monday-Friday: 9am to 7pm

Saturday: Closed

Sunday: Closed

18 Yucaixiang, Dongshuncheng St., Dadong Dist. 
Shenyang City, Liaoning 110042

18 Yucaixiang, Dongshuncheng St., Dadong Dist. 
Shenyang City, Liaoning 110042

© 2020 by Shenyang Tonglian Group